Umbilical cord mesenchymal stem cell transplantation for treatment of type 1 diabetes

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNC-10000986

Enrollment

Unknown

Registered

2010-08-03

Start date

2010-05-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes

Interventions

treatment:Umbilical cord mesenchymal stem cell transplantation

Eligibility

Sex/Gender

All

Age

5 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. primary type1 diabetes aged 5-70 years; 2. the current treatment are not satisfied and no acute complications tendency; 3. be able to tolerate intravascular intervention surgery.

Exclusion criteria

Exclusion criteria: 1. cancer; 2. serious heart disease or hypertension; 3. acute and chronic renal insufficiency or liver failure; 4. severe asthma or other severe respiratory insufficiency; 5. hemorrhagic disease, coagulopathy, contrast agent allergy or are being applied anticoagulant drugs; 6. congenital or acquired immunodeficiency diseases; 7. other endocrine and metabolic diseases.

Design outcomes

Primary

Measure	Time frame
Islet function;Blood sugar;Glycated hemoglobin;	—

Countries

China

Contacts

Public ContactYihua An

riveran@163.com+86 010 88276849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026